Latest Features

Diabetes Bone-Derived Factors in the Treatment of Diabetes

Bone-Derived Factors in the Treatment of Diabetes

A growing body of research highlights the important role of bone in glucose metabolism.

Practice Management Mistaking Legal Recourse for Evidence-Based Medical Practices in Surrogacy

Mistaking Legal Recourse for Evidence-Based Medical Practices in Surrogacy

Paying a surrogate to carry a fetus shoehorns a fourth, and fifth, party into the already tight therapeutic triangle formed by the biological mom, fetus, and physician.

Practice Management The Doctor Will @ You Now: Social Media MD Shares Strategies

The Doctor Will @ You Now: Social Media MD Shares Strategies

Farris K. Timimi, MD, and Lee Aase from the Mayo Clinic Social Media Network shared their views on the role of social media in physician practice.

Type 2 Diabetes Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes

Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes

Compared with the general population, patients with type 2 diabetes are at a 35% to 60% greater risk for atrial fibrillation.

Practice Management Doctors and the D Word: Talking About Death Is an Essential Skill — and One Often Lacking

Doctors and the D Word: Talking About Death Is an Essential Skill — and One Often Lacking

The reasons for physicians' discomfort with conversations about dying are as much cultural, social, and systemic as they are personal.

Type 2 Diabetes Update on the T2D-Dementia Link: Interview With Experts

Update on the T2D-Dementia Link: Interview With Experts

Endocrinology Advisor interviewed experts to explore mechanisms, clinical implications, and research needs pertaining to the diabetes-dementia link.

Diabetes PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes

PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes

Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.

Practice Management Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD

Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD

Despite their advantages, many clinicians do not necessarily agree with the centrality or content of CPGs. Others — especially primary care physicians (PCPs) — are overwhelmed by the vast and ever-increasing numbers of guidelines issued by multiple societies.

Pediatric Endocrinology "Is It Just a Phase?" What to Do When Transgender Youths Ask to Transition

"Is It Just a Phase?" What to Do When Transgender Youths Ask to Transition

In the last 5 years, many clinicians have faced tough questions about how best to serve transgender youth while doing no harm.

Practice Management Descriptive, Predictive Data at Odds in Medical Malpractice Courtroom

Descriptive, Predictive Data at Odds in Medical Malpractice Courtroom

Because they're busy looking in different directions, the principles "innocent until proven guilty" and "first, do no harm" don't always get along.

Androgen and Reproductive Disorders Reproductive Management in Multiple Sclerosis: Quick Takeaways for Your Practice

Reproductive Management in Multiple Sclerosis: Quick Takeaways for Your Practice

While it is now well-established that having MS should not limit patients' reproductive choices, this was not always the case.

Type 2 Diabetes Advisor Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes

Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes

According to a 2016 study, the mean price of insulin increased nearly 3-fold between 2002 and 2013.

Type 2 Diabetes Advisor The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches

The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches

Overweight and obesity are established risk factors for the development of metabolic diseases, including diabetes, hypertension, dyslipidemia, and cardiovascular disease.

Pediatric Endocrinology Smoothing the Care Team Transition for Youth With Type 1 Diabetes

Smoothing the Care Team Transition for Youth With Type 1 Diabetes

The transition from pediatric to adult care for type 1 diabetes should be a gradual process, with a plan to make the change when the patient is ready, not at a pre-determined time.

Pediatric Endocrinology Idiopathic Short Stature: Expert Perspectives

Idiopathic Short Stature: Expert Perspectives

Guidelines from The Endocrine Society, updated in 2017, advocate a shared decision-making approach regarding growth hormone therapy and advise against routine treatment for all children with idiopathic short stature.

Diabetes Detecting and Treating Depression in Diabetes

Detecting and Treating Depression in Diabetes

Comorbid depression, when not well controlled, can affect one's ability to self-manage diabetes. There can be loss of interest in making proper lifestyle choices, monitoring glucose levels, and taking one's medicines.

Type 2 Diabetes Advisor Type 2 Diabetes and Alzheimer Disease: What's the Connection?

Type 2 Diabetes and Alzheimer Disease: What's the Connection?

Findings suggest that insulin resistance and deficiency may increase the risk of Alzheimer disease via their influence on brain function.

Thyroid Subclinical Hypothyroidism: Controversies in Testing and Treatment

Subclinical Hypothyroidism: Controversies in Testing and Treatment

Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.

General Endocrinology Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?

Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?

Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.

Type 2 Diabetes Advisor Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment

Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment

Environmental causes of T2D and other metabolic disorders are often overlooked; a new body of evidence, however, is changing the clinical thinking about mitigating these effects on those at high risk of T2D.

Sign Up for Free e-Newsletters



CME Focus